Long Term Barrett's Endoscopic Mucosal Resection Study

Withdrawn

• Conditions: Barretts Esophagus

• Registration Number: NCT02200250
• Lead Sponsor: Professor Michael Bourke

Brief Summary

Analysis of long term outcomes of patients undergoing endoscopic mucosal resection for Barrett's oesophagus with high grade dysplasia and/or early intramucosal carcinoma (IMC).

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-07-17
• Study First Submitted QC: 2014-07-24
• Study First Posted: 2014-07-25
• Study Start: 2021-10-01
• Primary Completion: 2022-10
• Study Completion: 2022-10
• Status Verified: 2023-06
• Last Update Submitted: 2023-06-28
• Last Update Posted: 2023-07-03

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• 18 years or over
• Have or have had Barrett's Oesophagus

Exclusion Criteria

• Do not have Barrett's Oesophagus
• Have not had Barrett's Oesophagus resected at Westmead Hospital

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reviewing patients symptoms following resection	up to 3 years	Patients will be contacted via phone and will be required to answer questions over the phone. Health questionnaires may also be sent at the patients request to complete and post back.

Trial Locations

Locations (1)

Westmead Endoscopy Unit; 🇦🇺 Westmead, New South Wales, Australia